American Board of Pediatrics (ABP) · ABP Pediatric Hematology-Oncology Content Outline, effective April 1, 2019; initial-certification column. The ABP-authored outline was opened through ASPHO, whose current certification page continues to identify it as applicable. The workbook label maps to this physician subspecialty certification examination; the assigned slug is preserved. No separately dated 2026 outline was established.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• ABP Pediatric Hematology-Oncology Content Outline
• ASPHO: Certification in Pediatric Hematology/Oncology
• ABMS: American Board of Pediatrics
• NHLBI: Iron-Deficiency Anemia
• GeneReviews: EPB42-Related Hereditary Spherocytosis
• ASH Sickle Cell Disease Cerebrovascular Guidelines Snapshot
• ASH: Managing Cerebrovascular Disease in Sickle Cell Disease
• GeneReviews: Chronic Granulomatous Disease
• ASH: Management of Immune Thrombocytopenia Pocket Guide
• ASH Clinical Practice Guidelines on Immune Thrombocytopenia
• ASH ISTH NHF WFH: VWD Diagnosis Executive Summary
• CDC: Diagnosing Hemophilia
• GeneReviews: Fanconi Anemia
• Canadian Blood Services: Irradiated, Washed and CMV Seronegative Blood Components
• eviQ: Prevention of Tumour Lysis Syndrome
• COG: Pediatric Fever and Neutropenia Guideline, 2023 Update
• NCI: Late Effects of Treatment for Childhood Cancer
• NCI: Childhood Acute Lymphoblastic Leukemia Treatment
• NCI: Childhood Acute Myeloid Leukemia Treatment
• NCI: Neuroblastoma Treatment
• NCI: Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment
• NCI: Retinoblastoma Treatment
• NCI: Pediatric Allogeneic Hematopoietic Stem Cell Transplant
• NCI: Complications, GVHD and Late Effects After Pediatric HSCT
• CDC Field Epidemiology Manual: Analyzing and Interpreting Data
• 9789241596107-annex4.pdf
• ida_assessment_prevention_control.pdf
• 103946s5103lbl.pdf
• Childhood APL Treatment (PDQ®) - NCI
• Endogeneity in Logistic Regression Models - Volume 11, Number 3—March 2005 - Emerging Infectious Diseases journal - CDC
• Irradiated, washed and CMV seronegative blood components | Professional Education
• 020164s129lbl.pdf
• Childhood Non-Hodgkin Lymphoma Treatment (PDQ®) - NCI
• Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®) - NCI
• Ewing Sarcoma Treatment (PDQ®) - NCI
• Childhood Medulloblastoma and Other CNS Embryonal Tumors (PDQ®) - NCI
• JCI - A novel leukocyte adhesion deficiency caused by expressed but nonfunctional β2 integrins Mac-1 and LFA-1
• Client Challenge
• ash-cpg-aplastic-anemia-pocket-guide-6-panel-0320-nocropmarks.pdf
• Transfusion reactions | Professional Education
• These highlights do not include all the information needed to use Elitek safely and effectively. See full prescribing information for Elitek®. ELITEK (rasburicase) for injection, for intravenous useInitial U.S. Approval: 2002
• COG_LTFU_Guidelines_Only_v6.pdf